The quest for multi-functional medicines [electronic resource] : path for progress, the SERM story. Lecture 2 / V. Craig Jordan.
Material type: FilmSeries: Henry Stewart talksBiomedical & life sciences collection: Publisher: London : Henry Stewart Talks, 2011Description: 1 online resource (1 streaming video file (31 min.) : color, sound)Subject(s): Selective estrogen receptor modulators | Selective Estrogen Receptor Modulators -- pharmacology | Selective Estrogen Receptor Modulators -- therapeutic useOnline resources: Click here to access onlineAnimated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Selected Estrogen Receptor Modulators (SERMs) are a group of medicines that switch on and switch off estrogen target sites around a post-menopausal woman's body. They are anti-estrogenic and block estrogen activated breast cancer growth and increase bone density and lower cholesterol, which are estrogenic properties. Raloxifene is a pioneering SERM used to prevent and treat osteoporosis and is approved in the United States of America to reduce the risk of breast cancer in post-menopausal women.
Access restricted to subscribers.
Mode of access: World Wide Web.